APA (7th ed.) Citation

J, W., Y, Y., DA, L. P., D, F., CJ, P., TM, S., . . . MR, G. (2021). Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(12), 3298. https://doi.org/10.1158/1078-0432.CCR-20-4730

Chicago Style (17th ed.) Citation

J, Wu, et al. "Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27, no. 12 (2021): 3298. https://doi.org/10.1158/1078-0432.CCR-20-4730.

MLA (9th ed.) Citation

J, Wu, et al. "Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 12, 2021, p. 3298, https://doi.org/10.1158/1078-0432.CCR-20-4730.